Microneedle Intra-Arterial Injection for Retinal Artery Occlusion — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Microneedle Intra-Arterial Injection for Retinal Artery Occlusion — Stella

Home/Central Retinal Artery Occlusion/

View on ClinicalTrials.gov

Recruiting

Back to Central Retinal Artery Occlusion trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Eye Center of the Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang

Key details

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~24 participants

Started

September 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.